Ogorek Anthony Joseph’s AstraZeneca AZN Stock Holding History

Ogorek Anthony Joseph’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$39K	Hold	208	–	–	0.01%	208
2026 Q1	$41K	Sell	208 -1	-0.5%	-$193	0.01%	183
2025 Q4	$38K	Hold	209	–	–	0.01%	190
2025 Q3	$32K	Buy	209 +2	+1%	+$303	0.01%	213
2025 Q2	$28K	Hold	207	–	–	0.01%	221
2025 Q1	$30K	Buy	207 +2	+1%	+$289	0.01%	214
2024 Q4	$26K	Hold	205	–	–	0.01%	158
2024 Q3	$31K	Buy	205 +10	+5%	+$1.61K	0.01%	144
2024 Q2	$30K	Hold	195	–	–	0.01%	136
2024 Q1	$26K	Buy	195 +3	+2%	+$397	0.01%	147
2023 Q4	$25K	Hold	192	–	–	0.01%	154
2023 Q3	$26K	Hold	192	–	–	0.01%	146
2023 Q2	$27K	Hold	192	–	–	0.01%	139
2023 Q1	$26K	Hold	192	–	–	0.01%	135
2022 Q4	$26K	Hold	192	–	–	0.01%	99
2022 Q3	$21K	Hold	192	–	–	0.01%	106
2022 Q2	$25K	Hold	192	–	–	0.01%	102
2022 Q1	$25K	Hold	192	–	–	0.01%	117
2021 Q4	$22K	Hold	192	–	–	0.01%	129
2021 Q3	$23K	Hold	192	–	–	0.01%	118
2021 Q2	$23K	Hold	192	–	–	0.01%	114
2021 Q1	$19K	Hold	192	–	–	0.01%	119
2020 Q4	$19K	Hold	192	–	–	0.01%	101
2020 Q3	$21K	Hold	192	–	–	0.01%	77
2020 Q2	$20K	Hold	192	–	–	0.01%	75
2020 Q1	$17K	Hold	192	–	–	0.01%	81
2019 Q4	$19K	Buy	+192	New	+$18.1K	0.01%	88

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Ogorek Anthony Joseph's AZN Position: Q2 2026 in Review

Ogorek Anthony Joseph held its AstraZeneca (AZN) position steady in Q2 2026 at 208 shares worth $39K. The position accounts for 0.01% of the portfolio, ranked #208.

Ogorek Anthony Joseph first reported a position in AZN in Q4 2019 and has held it in 27 quarters since. The position peaked at $41K in Q1 2026. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Ogorek Anthony Joseph held 208 shares of AstraZeneca worth $39K as of Q2 2026.
Ogorek Anthony Joseph left its AstraZeneca share count unchanged in Q2 2026.
AstraZeneca made up 0.01% of Ogorek Anthony Joseph's portfolio in Q2 2026, its #208 holding.
Ogorek Anthony Joseph first reported a position in AstraZeneca in Q4 2019 and has held it in 27 quarters since.
Ogorek Anthony Joseph's AstraZeneca position peaked at $41K in Q1 2026.
1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Ogorek Anthony Joseph's 13F filing for Q2 2026, filed 7 Aug 2026.